{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:43:24Z","timestamp":1787168604560,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sleep.2025.106602","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T02:44:21Z","timestamp":1748486661000},"page":"106602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Weight changes during treatment with low-sodium oxybate in two phase 3 clinical studies in participants with narcolepsy or idiopathic hypersomnia"],"prefix":"10.1016","volume":"133","author":[{"given":"Nancy","family":"Foldvary-Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Steininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Measey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Candler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.sleep.2025.106602_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13631","article-title":"Narcolepsy","volume":"31","author":"Barateau","year":"2022","journal-title":"J Sleep Res"},{"issue":"9","key":"10.1016\/j.sleep.2025.106602_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2025.106602_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5664\/jcsm.9638","article-title":"Disrupted nighttime sleep and sleep instability in narcolepsy","volume":"18","author":"Maski","year":"2022","journal-title":"J Clin Sleep Med"},{"issue":"14","key":"10.1016\/j.sleep.2025.106602_bib4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.0000000000003787","article-title":"Measurement of narcolepsy symptoms: the narcolepsy severity scale","volume":"88","author":"Dauvilliers","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2025.106602_bib5","series-title":"International Classification of Sleep Disorders \u2013 Third Edition, Text Revision","year":"2023"},{"issue":"5","key":"10.1016\/j.sleep.2025.106602_bib6","first-page":"631","article-title":"Obesity accompanies narcolepsy with cataplexy but not narcolepsy without cataplexy","volume":"31","author":"Sonka","year":"2010","journal-title":"Neuroendocrinol Lett"},{"issue":"10","key":"10.1016\/j.sleep.2025.106602_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad161","article-title":"Cardiovascular burden of narcolepsy disease (CV-BOND): a real-world evidence study","volume":"46","author":"Ben-Joseph","year":"2023","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2025.106602_bib8","doi-asserted-by":"crossref","first-page":"zsad213","DOI":"10.1093\/sleep\/zsad213","article-title":"Cardiovascular burden of narcolepsy: what have we learned and what do we still need to know?","volume":"46","author":"Barateau","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106602_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.sleep.2016.04.004","article-title":"Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study","volume":"33","author":"Black","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106602_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.sleep.2017.11.1125","article-title":"Comorbidities in a community sample of narcolepsy","volume":"43","author":"Cohen","year":"2018","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.sleep.2025.106602_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","article-title":"Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population","volume":"14","author":"Ohayon","year":"2013","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2025.106602_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/oby.2003.156","article-title":"Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity","volume":"11","author":"Kok","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/j.sleep.2025.106602_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2020.101306","article-title":"Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts","volume":"52","author":"Lammers","year":"2020","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.106602_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepe.2023.100059","article-title":"Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States","volume":"3","author":"Saad","year":"2023","journal-title":"Sleep Epidemiol"},{"issue":"1","key":"10.1016\/j.sleep.2025.106602_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/WNL.0000000000003432","article-title":"Comorbidity between central disorders of hypersomnolence and immune-based disorders","volume":"88","author":"Barateau","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2025.106602_bib16","unstructured":"Xywav\u00ae (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIII [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; 2023."},{"issue":"19","key":"10.1016\/j.sleep.2025.106602_bib17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJM199511093331917","article-title":"Declaring the sodium content of drug products","volume":"333","author":"Szarfman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2025.106602_bib18","unstructured":"US Food and Drug Administration. Clinical review for binosto, NDA 202344. US Food and Drug Administration 2012. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/202344Orig1s000MedR.pdf. [Accessed 28 February 2023]."},{"key":"10.1016\/j.sleep.2025.106602_bib19","unstructured":"US Food and Drug Administration. Quantitative labeling of sodium, potassium, and phosphorus for human over-the-counter and prescription drug products. Guidance for Industry. US Food and Drug Administration 2022. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/quantitative-labeling-sodium-potassium-and-phosphorus-human-over-counter-and-prescription-drug. [Accessed 11 October 2022]."},{"issue":"3","key":"10.1016\/j.sleep.2025.106602_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa206","article-title":"Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy","volume":"44","author":"Bogan","year":"2021","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2025.106602_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1474-4422(21)00368-9","article-title":"Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study","volume":"21","author":"Dauvilliers","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2025.106602_bib22","unstructured":"US Food and Drug Administration. Clinical superiority findings. US Food and Drug Administration 2021. https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/clinical-superiority-findings. [Accessed 9 July 2021]."},{"key":"10.1016\/j.sleep.2025.106602_bib23","unstructured":"Lumryz\u2122 (sodium oxybate) for extended-release oral solution, CIII [prescribing information]. Chesterfield, MO: Avadel CNS Pharmaceuticals; 2024."},{"key":"10.1016\/j.sleep.2025.106602_bib24","unstructured":"Xyrem\u00ae (sodium oxybate) oral solution, CIII [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc.; 2023."},{"issue":"6","key":"10.1016\/j.sleep.2025.106602_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sleep.2008.05.012","article-title":"Weight loss in narcolepsy patients treated with sodium oxybate","volume":"10","author":"Husain","year":"2009","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2025.106602_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12684","article-title":"Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1","volume":"28","author":"Schinkelshoek","year":"2019","journal-title":"J Sleep Res"},{"issue":"7","key":"10.1016\/j.sleep.2025.106602_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S2352-4642(18)30133-0","article-title":"Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation","volume":"2","author":"Plazzi","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.sleep.2025.106602_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5664\/jcsm.10912","article-title":"Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy","volume":"20","author":"Dauvilliers","year":"2024","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2025.106602_bib29","unstructured":"US Food and Drug Administration. Guidance for industry developing products for weight management. US Food and Drug Administration 2007. https:\/\/www.fda.gov\/media\/71252\/download. [Accessed 14 November 2023]."},{"issue":"4","key":"10.1016\/j.sleep.2025.106602_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5665\/sleep.3592","article-title":"Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study","volume":"37","author":"Donjacour","year":"2014","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2025.106602_bib31","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1212\/WNL.0000000000013128","article-title":"Metabolomics signature of patients with narcolepsy","volume":"98","author":"Dauvilliers","year":"2022","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.sleep.2025.106602_bib32","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.sleep.2025.106602_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.pbb.2008.05.018","article-title":"Modafinil decreases food intake in humans subjected to simulated shift work","volume":"90","author":"Perez","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.sleep.2025.106602_bib34","series-title":"Dextroamphetamine sulfate [package insert]","year":"2016"},{"key":"10.1016\/j.sleep.2025.106602_bib35","series-title":"Adderall [package insert]","year":"2017"},{"issue":"5","key":"10.1016\/j.sleep.2025.106602_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000511023","article-title":"Obesity prevalence in the long-term future in 18 European countries and in the USA","volume":"13","author":"Janssen","year":"2020","journal-title":"Obes Facts"},{"issue":"158","key":"10.1016\/j.sleep.2025.106602_bib37","article-title":"National Health and Nutrition Examination Survey 2017-March 2020 prepandemic data files-development of files and prevalence estimates for selected health outcomes","author":"Stierman","year":"2021","journal-title":"Natl Health Stat Rep"},{"issue":"3","key":"10.1016\/j.sleep.2025.106602_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/jcm12030925","article-title":"Prevalence of overweight and obesity in France: the 2020 obepi-roche study by the \"ligue Contre l'Ob\u00e9sit\u00e9\"","volume":"12","author":"Fontbonne","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.sleep.2025.106602_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","article-title":"Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy","volume":"10","author":"Ristanovic","year":"2009","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2025.106602_bib40","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.70.7.614","article-title":"Managing weight gain as a side effect of antidepressant therapy","volume":"70","author":"Deshmukh","year":"2003","journal-title":"Cleve Clin J Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:01:16Z","timestamp":1762545676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725002771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S1389945725002771"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106602","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight changes during treatment with low-sodium oxybate in two phase 3 clinical studies in participants with narcolepsy or idiopathic hypersomnia","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106602"}}